Regulation of coagulation factors during liver regeneration in mice: mechanism of factor VIII elevation in plasma.

INTRODUCTIONS The profiles of coagulation factor production during liver regeneration process remains to be fully elucidated. The present study was aimed to perform a comprehensive analysis whether hepatic gene expression was differentially regulated relative to the secretion of biologically active coagulation factors using a mouse model of liver regeneration. MATERIALS AND METHODS Liver regeneration was induced by performing a 2/3 partial hepatectomy (PHx). Plasma samples were assessed for coagulation factor activities (fibrinogen, prothrombin, V, VII, VIII, IX, X, XI, XII, and XIII) and the liver mRNA levels of coagulation, anti-coagulation, and fibrinolytic factors were quantified by real-time RT-PCR during the phase of liver regeneration. RESULTS At the peak of liver regeneration, the expression levels for all of the genes analyzed were found to be reduced in a time-dependent manner. Consistent with the gene expression levels, plasma activities of all coagulation factors, except for FVIII, were temporally declined during the same time frame. FVIII paradoxically demonstrated a significant increase (P<0.05) in plasma activities concomitant with the decrease of liver mRNA expression levels. We found that the increase in plasma FVIII activities might be associated with (1) a delay in the inactivation of plasma FVIII caused by increased VWF in plasma and decreased FVIII clearance in the liver, (2) the rapid release of FVIII from the storage sites, and (3) the alteration of intracellular trafficking pathway of FVIII. CONCLUSIONS The present study demonstrated that the process of liver regeneration involves a general reduction for many of the coagulation cascade proteins, but there are paradoxical increases in plasma levels of FVIII and VWF.

[1]  J. Belghiti,et al.  Hypercoagulability after partial liver resection , 2007, Thrombosis and Haemostasis.

[2]  T. Okano,et al.  Successful in vivo propagation of factor IX-producing hepatocytes in mice: Potential for cell-based therapy in haemophilia B , 2008, Thrombosis and Haemostasis.

[3]  T. M. Gulik,et al.  Extra‐hepatic factor VIII expression in porcine fulminant hepatic failure , 2005, Journal of thrombosis and haemostasis : JTH.

[4]  T. Starzl,et al.  Liver Transplantation in Hemophilia A , 1987 .

[5]  R. Blaheta,et al.  Long‐term production of major coagulation factors and inhibitors by primary human hepatocytes in vitro: perspectives for clinical application , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[6]  F. Cajone,et al.  Protein synthesis in regenerating liver. , 1980, The International journal of biochemistry.

[7]  T. Okano,et al.  Effects on coagulation factor production following primary hepatomitogen-induced direct hyperplasia. , 2009, World journal of gastroenterology.

[8]  N. Fausto,et al.  Liver regeneration , 2006, Hepatology.

[9]  P. Meda,et al.  Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo. , 2002, Blood.

[10]  M. Puder,et al.  Partial Hepatectomy in the Mouse: Technique and Perioperative Management , 2003, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[11]  M. Matsumoto,et al.  Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: Observations in 3 cases , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  D. Stirling,et al.  Effects of acute liver injury on blood coagulation , 2003, Journal of thrombosis and haemostasis : JTH.

[13]  松尾 拓哉 Control mechanism of the circadian clock for timing of cell division in vivo , 2004 .

[14]  A. Asano,et al.  [Hemophilia B]. , 1998, Ryoikibetsu shokogun shirizu.

[15]  M. Dake,et al.  Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases , 2005, Hepatology.

[16]  C. Kirkpatrick,et al.  FVIII production by human lung microvascular endothelial cells. , 2006, Blood.

[17]  Gozoh Tsujimoto,et al.  Gene expression profile in the regenerating rat liver after partial hepatectomy. , 2003, Journal of hepatology.

[18]  H. Forst,et al.  [Liver transplantation in hemophilia A?]. , 1995, Der Internist.

[19]  Paolo Bucciarelli,et al.  High levels of factor VIII and risk of extra-hepatic portal vein obstruction. , 2009, Journal of hepatology.

[20]  I. Mikhailenko,et al.  Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism* , 1999, The Journal of Biological Chemistry.

[21]  H. Hauri,et al.  LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII 1 , 2003, Journal of thrombosis and haemostasis : JTH.

[22]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[23]  Masayuki Yamato,et al.  Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets , 2007, Nature Medicine.

[24]  Jean S. Campbell,et al.  Liver regeneration. , 2012, Journal of hepatology.

[25]  R. Sarkar,et al.  Transplantation of endothelial cells corrects the phenotype in hemophilia A mice , 2005, Journal of thrombosis and haemostasis : JTH.

[26]  Mario Berger,et al.  High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII , 2004, Thrombosis and Haemostasis.

[27]  T. Okano,et al.  Suitable reference genes for the analysis of direct hyperplasia in mice. , 2008, Biochemical and biophysical research communications.

[28]  Claus Lindbjerg Andersen,et al.  Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.

[29]  J. V. van Mourik,et al.  Tissue Distribution of Factor VIII Gene Expression In Vivo – A Closer Look , 2001, Thrombosis and Haemostasis.

[30]  M. Rizzetto,et al.  Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  T. Okano,et al.  Reference gene selection for real-time RT-PCR in regenerating mouse livers. , 2008, Biochemical and biophysical research communications.

[32]  J. Saric,et al.  Secretion of functional plasma haemostasis proteins in long‐term primary cultures of human hepatocytes , 2004, British journal of haematology.

[33]  T. Okano,et al.  Therapeutic effects of hepatocyte transplantation on hemophilia B. , 2008, Transplantation.

[34]  R. Montgomery,et al.  Regulated release of VWF and FVIII and the biologic implications , 2006, Pediatric blood & cancer.

[35]  B. Mausbach,et al.  The role of stress hormones in the relationship between resting blood pressure and coagulation activity , 2006, Journal of hypertension.